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a r t ic l e
Mutations in the gene encoding the 
inwardly-rectifying renal potassium channel, ROMK, 
cause the antenatal variant of Bartter syndrome: 
evidence for genetic heterogeneity
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Inherited renal tubular disorders associated with hypokalemic alkalosis (Bartter-like syndromes) can be 
subdivided into at least three clinical phenotypes: (i) the hypocalciuric-hypomagnesemic Gitelman variant; (ii) the 
classic variant; and (iii) the antenatal hypercalciuric variant (also termed hyperprostaglandin E syndrome). 
Mutations in the Na-CI cotransporter (NCCT) underlie the pathogenesis of the Gitelman variant and mutations in 
the Na-K-2CI cotransporter (NKCC2) have recently been identified in the antenatal hypercalciuric variant. We now 
describe mutations in the gene encoding the inwardly-rectifying potassium channel, ROMK, in eight kindreds with 
the antenatal variant of Bartter syndrome. These findings indicate that antenatal Bartter syndrome is genetically 
heterogeneous and provide new insights into the molecular pathogenesis of Bartter-like syndromes.
a
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INTRODUCTION
Bartter syndrome encompasses a set of primary renal tubular 
disorders associated with hypokalemic metabolic alkalosis; often 
increased urinary prostaglandin excretion; hyperreninemic 
hyperaidosteronism with normal blood pressure; and hypexplasia 
of the juxtaglomerular apparatus (1). Within this relatively rare 
set of disorders, familial cases occur commonly and inheritance 
best fits with autosomal recessive transmission (2,3), This set of 
disorders can be subdivided into at least three clinical phenotypes:
(i) the hypocalciuric-hypomagnesemic variant described by 
Gitelman et aL\ (ii) the classic syndrome originally described by 
Bartter et aL; and (iii) the antenatal hypercalciuric variant 
associated with severe systemic manifestations (3-6).
Among these disorders, Gitelman syndrome is characterized by a 
relatively mild course and late age of onset. Profound hypokalemia 
and hypomagnesemia lead to the major manifestations of fatigue, 
muscle weakness and recurrent episodes of tetany (7,8). 
Hypocalciuria and mildly impaired urinary concentrating ability are 
constant features of this sub-type (9). Recent studies demonstrate 
that this disorder results from presumptive loss o f function mutations 
in the gene encoding the thiazide-sensitive sodium-chloride (Na-Cl) 
cotransporter (NCCT) of the distal nephron (10). Genetic 
homogeneity in Gitelman syndrome has been confirmed in 
subsequent studies (11,12).
In comparison, patients with classic Bartter syndrome (CBS) 
generally present during early childhood. These patients fulfill 
the core criteria of Bartter’s original description without
Table 1. Clinical characteristics of index patients with antenatal Bartter syndromea
associated tetanic episodes or profound hypercalciuria (3,6,13). 
Typically, urinary calcium excretion is normal or slightly elevated 
and urinary concentrating capacity is close to normal (9,14). 
While much attention has been focused on defective chloride 
transport in the medullary thick ascending limb of the loop of 
Henle (mTAL) as the proximate abnormality in CBS (15-18), the 
underlying defect in the classic variant remains to be elucidated.
Finally, the antenatal variant of Bartter syndrome (ABS) is a 
life-threatening disorder in which both the renal tubular 
hypokalemic alkalosis as well as profound systemic symptoms 
are manifest (5,19,20). The abnormalities begin in utero with 
marked fetal polyuria that leads to polyhydramnios between 24 
and 30 weeks gestation and typically, premature delivery 
(5,19-21). The amniotic fluid contains high chloride levels but 
normal concentrations of sodium, potassium, calcium and 
prostaglandin E? (22). Affected neonates have severe salt wasting 
and hyposthenuria, moderate hypokalemic metabolic alkalosis, 
hyperprostaglandinuria and failure to thrive. An essential 
manifestation is matted hypercalciuria and as a secondary 
consequence affected infants develop nephrocalcinosis and 
osteopenia (23-26). The fever, vomiting and occasional 
diarrhoea associated with this disorder has been attributed to the 
stimulation of renal and systemic prostaglandin E2 activity in 
affected infants and these symptoms are effectively treated with 
inhibitors of prostaglandin synthesis. Based on these clinical 
features, the term hyperprostaglandin E syndrome was coined to 
describe this antenatal variant of Bartter syndrome (27).
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Figure 1. Pedigrees and haplotypes of antenatal Bartter syndrome families not linked to the chromosome 15 NKCC2 interval. For each child, the paternal chromosome 
is represented on the left and the maternal chromosome on the right. The thin lines indicate uninformative markers.
Recent studies have demonstrated mutations in the gene 
encoding the mTAL luminal bumetanide-sensitive Na'K-2Cl 
cotransporter (.NKCC2) in a cohort of five ABS kindreds (28). 
These genetic data indicate that the antenatal variant of Bartter 
syndrome results from a primary defect in mTAL chloride 
transport. This hypothesis is consistent with clinical studies 
demonstrating that ABS patients have an impaired diuretic 
response to furosemide (29). However, in applying haplotype 
analyses with polymorphic chromosome 15 markers tightly 
linked to NKCC2 in our cohort of 14 antenatal Bartter syndrome 
families, we excluded NKCC2 as the disease-susceptibility locus 
in six families.
Transepithelial chloride transport in the mTAL involves an 
inteiplay between the apical Na-K-2C1 cotransporter (NKCC2), 
the luminal, ATP-regulated potassium channel, ROMK (KCNJ1), 
the basolateral chloride channel (C/C), a basolateral K~C1 
cotransporter, and the Na-K-ATPase (reviewed in 30,31). 
Therefore, defective chloride transport may result from loss of 
function mutations in any of the genes encoding these channels 
or cotransporters. We now report the identification of mutations 
in the ROMK gene (.KCNJ1) in three kindreds and five sporadic 
cases with ABS. These findings indicate that the antenatal variant 
of Bartter syndrome is genetically heterogeneous.
RESULTS
Antenatal Bartter syndrome kindreds
We have identified a cohort of 14 families with antenatal Bartter 
syndrome and five sporadic cases for study (Table 1). In nine of 
these families, the affected children were the products of 
consanguineous unions. All index cases had a history of 
polyhydramnios and premature delivery. Postnatally, patients 
developed hypokalemic alkalosis and all had hyposthenuria. 
Prior to the initiation of indomethacin therapy, all affected infants 
had failed to thrive with growth parameters less than the third
percentile for age. Urinary excretion rates of prostaglandin E2 
(PGE2) and/or its major metabolite, prostaglandin E-M (PGE-M) 
were markedly elevated (100% above upper limit of normal) in 
all patients in whom these measurements were performed. 
Hypercalciuria with associated sonographic evidence of 
nephrocalcinosis was demonstrated in all 14 kindreds. Isolated 
hypercalciuria was detected in one sporadic case who was treated 
in the immediate postnatal period with indomethacin. Renal 
biopsies obtained for three unrelated hypercalciuric infants 
(index cases from families AB.Paris2, AB.Marb5 and 
AB.MarbS2) revealed medullary calcifications with associated 
tubular atrophy, interstitial inflammation and fibrosis.
Genotype analysis
9
Initially, we sought to determine whether the NKCC2 gene was the 
disease-susceptibility locus in our ABS families. Markers tightly 
linked to the NKCC2 locus on chromosome 15 were typed in these 
kindreds. Lod scores for this set of markers were not conclusive 
(data not shown), which raised the possibility of genetic hetero­
geneity in our ABS cohort. Haplotypes constructed for these 
pedigrees demonstrate that six ABS families (AB.Paris2, AB.Paris5, 
AB.Paris6, AB.Marb3, AB.Marb4 and AB.Marb5) are not linked 
to the NKCC2 locus either because two affected siblings do not 
share the same haplotypes or an affected child from a consan­
guineous union is not homozygous for markers of the NKCC2 
gene interval (Fig. 1). Of note, there were no clinical or laboratory 
features that distinguish the group linked to NKCC2 and the group 
unlinked to this locus (Table 1).
In those families where the NKCC2 gene is excluded as the 
disease-susceptibility locus, we evaluated whether ABS is linked 
to the gene encoding ROMK, the inwardly-rectifying, ATP-regu- 
lated, potassium channel. Fluorescence in situ hybridization has 
■ mapped the ROMK gene, KCNJ1, to chromosome llq24-25 
(32,33). Therefore, we typed these families for a set of five 
microsatellite markers that spanned a 14 cM candidate interval on
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Figure 2. Pedigrees and haplotypes of Bartter syndrome families with apparent linkage to chromosome 11 markers that flank the KCNJJ gene. In the consanguineous 
families, the regions of homozygosity are framed with a solid line. In those families in which consanguinity cannot be confirmed, regions of homozygosity are framed 
with a dotted line.
chromosome 11 q24—q25. The haplotype data for these six 
families suggested linkage between ABS and the KCNJ1 gene 
(Fig. 2). In two of the consanguineous families, (AB.Paris2 and 
AB.Paris6), the affected children are homozygous for the 9 cM 
interval between D11S912 and D11S1320. Since a homozygous 
mutation has been found in family AB.MarbS (see below), the 
region of homozygosity defined by this family allows us to 
position the KCNJI gene in the genetic interval flanked by 
D1IS912 and D11S9.10. Given the haplotype data, we initiated a 
search for mutations in the KCNJI gene in these six families and 
the five sporadic cases.
Mutation analysis of the human KCNJI gene in 
antenatal Bartter syndrome kindreds
Previous studies by Shuck et al. have demonstrated that the gene 
encoding human ROMK produces five distinct transcripts by 
differential splicing of its five exons (34). All five transcripts 
share a common 3' exon (exon 5) that encodes the majority of the 
channel protein. The largest product, ROMK-1, is initiated at a 
start codon in exon 4, contains 391 amino acid residues, and is the 
most efficiently translated isoform (34). Based on the sequence 
of ROMK-1, sets of primer pairs were used to amplify the coding 
sequence for exon 4 and exon 5 from genomic DNA of our test 
families (Table 2). The amplified products were analyzed by 
single-strand conformation polymorphism analysis (SSCA). 
Aberrant SSCA patterns were detected for exon 5 in three 
consanguineous families (AB.Paris2, AB.Marb3 and AB.Marb4) 
and the five sporadic cases. The affected children in the 
consanguineous families were homozygous for these aberrations. 
None of these aberrant SSCA patterns has been observed in 
examination of at least 50 normal unrelated Caucasian controls 
(100 test alleles).
In total, 11 mutations were identified and four of these 
mutations were homozygous (Table 3; Fig. 3). Sequence analysis 
reveals that these mutations are distributed throughout the 
ROMK-1 protein (Fig. 4). Nine mutations are missense, causing 
substitutions of residues which are highly conserved in wild-type 
human, rat and Xenopus laevis. One mutation introduces a stop 
codon that deletes the terminal 63 residues of the channel protein 
and one 4 bp deletion causes a frameshift that results in a 
truncated, 351 amino acid protein. All of these mutations were 
inferred to alter the ROMK protein structure.
Mutations in the KCNJI gene have not been detected in 
families AB.ParisS, AB.Paris6 or AB.MarbS. It is possible that 
these families have KCNJI gene mutations involving the 
exon-intron splice junctions of exon 4 or exon 5 or in an as yet 
unexamined exon. In addition, we cannot exclude the possibility 
that another gene may be the disease-susceptibility locus in these 
families.
DISCUSSION
Antenatal Bartter syndrome is aphenotypically distinct variant of 
the Bartter-like syndromes characterized by polyhydramnios 
with preterm delivery, severe salt wasting, hyposthenuria, and 
hypercalciuria (Table 1). Our identification of 11 independent 
mutations in the gene KCNJI that segregate specifically with 
ABS and result in either non-conservative amino acid substitu­
tions in important functional domains or premature truncation of 
the channel protein indicate that defects in KCNJI cause the 
antenatal variant of Bartter syndrome. These findings demon­
strate that ABS is genetically heterogeneous, involving mutations 
in KCNJI as well as NKCC2 (28).
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Table 2. PCR primers for SSCA analysis of the human KCNJ] gene exons 4 and 5 (5'-»3')
Primer name
hR0MKex4
hROMKex5.5
hROMKex5.4
hROMKex5.3
hROMKex5.2
hR0MKex5.1
Forward primer Reverse primer
GCATAGAAAGACCAACAA 
TTGATGTGTTTTCAGATCA 
AAGTGGAGATACAAAATGACC 
TATGGATTCAGGTGTGTG 
CTTATTGGCAGTCACATTTA 
CTACCGTTTTGCTCCCATA
ACTTACC A ACGTGT CAA A
GGAGGTCTTTGTGAATGTA
GCAGAAAAATGGCAGTGG
AAAATAATGGTCTCTCCT
TATTTCCCTTCCTTTGTCTT
ACTTTG CTTTACTC CTGTfG A A
Based on the sequence pieviously repoited by Shuck et al. (34), a single primer pair was designed to amplify exon 4 and a set of nested primer pairs were designed 
to amplify the coding region of exon 5.
Table 3. Mutations in the human ROMK gene (KCNJI) in antenatal Bartter syndrome
Ethnic origin Mutation Nucleotide Consequence Mutation #
Families
AB.Paris2 North Africa A198T G—»A at 1153 Ala->Thr at 198 1
AB.Marb3 India G167E G-»A at 1062 Gîy-^Glu at 167 2
AB.Marb4 Turkey D108H G—>C at 883 Asp~>His at 108 3
Sporadic cases
AB.MarbS 1 Germany/Croatia P110L C-*T at 890 Pro~>Leu at 110 4
V72E T—»A at 776 Val-»Glu at 72 5
AB.MarbS2 Germany V315G T—>G at 1505 Val->Gly at 315 6
1557del AAAG 4 bp deletion from 1557 frameshift-^Stop 36 aa downstream 7
AB.NijSl Netherlands W99C G—>T at 858 Trp~»Cys at 99 
«
8
AB.FreiSl Belgium A198T G—»A at 1153 Ala—»Thr at 198 1
R338X C-»T at 1573 Arg-»Stop at 338 9
AB.ParisSl France V122E T~>A at 926 Val~>Glu at 122 10
D74Y G—>T at 781 Asp—»Tyr at 74 11
Sense strand sequences are shown. Amino acids are numbered from the first Met in exon 4. The mutation # refers to the mutation position in Figure 4. Nucleotides 
are numbered as in Shuck et a I. (34).
The ROMK gene is a disease-susceptibility gene in 
antenatal Bartter syndrome
KCNJI encodes the luminal, ATP-sensitive, potassium channel in 
the distal nephron (35-37). This channel belongs to a family of 
inwardly rectifying potassium channels (Kir family; ROMK is 
Kir 1.1) and is characterized by little-to-no voltage dependence, 
inward rectification, exquisite pH-sensitivity and modulation by 
ATP (31,38-40). The ROMK channel is involved in potassium 
secretion in the TAL and the distal nephron. In the mTAL, this 
secretory function recycles potassium across the apical mem­
brane, thus ensuring that adequate luminal potassium is available 
for the efficient functioning of the Na-K-2C1 cotransporter (41). 
Inhibition of luminal potassium channels reduces NaCl reabsorp­
tion in this nephron segment (42). In human kidney, differential 
splicing produces five distinct transcripts of ROMK. While the 
relative distribution of these isoforms in distal nephron segments 
has not been established, exon 5 is common to all of these 
isoforms and encodes the majority of the channel protein (33,34). 
The detection of 11 independent mutations involving this 
common exon predicts that ROMK activity is disrupted in our 
cohort of ABS patients.
We have identified mutations involving the amphipathic MO 
segment; the Ml and M2 transmembrane segments; the M1-H5 
linker segment that comprises the channel pore; the putative 
ATP-binding domain; and the C-terminus of the ROMK channel 
protein (Fig. 4). Two non-conservative missense mutations 
within the MO region of the N-terminus have been identified, 
V72G (mutation #5 in Table 3, Fig. 4) and D74Y (mutation #11). 
This region of ROMK has been implicated in internal pH 
regulation of ROMK (43). Since this channel is exquisitely 
sensitive to reductions in cytosolic pH, these mutations in MO 
could significantly alter ROMK channel function. The homo­
zygous missense mutation, W99C (mutation #8), that involves 
the substitution of a polar cystine for Trp-99 in the M l domain is 
likely to alter the configuration of the channel pore and thus, 
would be predicted to disrupt channel function. The missense 
mutations in AB.Marb4 (mutation #3), AB.MarbS 1 (mutation 
#4) and AB.ParisSl (mutation #10) all cause non-conservative 
amino acid changes in the M1-H5 linker region. Experimental 
studies have demonstrated that this segment is important in 
external pH regulation of the inwardly-rectifying potassium 
channels, HIR (44) and ROMK. Mutation of the glycosylation 
site, Asn-117, in this region of ROMK has been shown to
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(Walker A site) that have been shown to be important in the 
non-hydrolytie Mg2+-ATP regulation of ROMK (37). Both PKA 
(35,47) and PKC (37,48) are important regulators of ROMK 
function and structural alterations due to non-conservative amino 
acid substitutions within this region may disrupt channel 
regulation. Of note, the same A198T mutation was found in a
homozygous missense mutation* A lWF (mutation #1 h causes a non-related compound heterozygote (AB.FreiS 1 ). That this
• b •' 't"-\ i ''V . ,'A .j .. -i y;. . s.*.h¿ -1 fi.» * V , * • ‘‘ .• yuv.-iWf."r .'4:^t >•?<W . * f W p .n***?*«Tti twnwä<»Ai wwi eW KW
Vi^tìrv 3. Mkiuti0n;tl an.itysis with the Kt 'S tf  ^ene in antenatal Hunter syndrome patients. Aberrant hand patterns were identified by SSCA ami evaluated by DNA 
sequeiKe an.th si*. I’.tn^nf^ are uSrnnticd as m Table 1. A representative .sample of eight inutations in six patients are shown, Bach composite panel shows the sequence 
viata horn a urnlM  individual and Ute arkvted imlivitlual on the left and a representative autoradiograph ol‘ the SSCA pattern on the right. The sequence of the sense 
strand is sfornii uni,;* ^  nuhwated, lAUn imkx case A IU ‘ans2, the first base ofctKlon lL)H is mutated irom G to A causing the A 19XT substitution. (H) In
imk*v wa^ - \H ifo; \\\%c %\\ H>? is mutated irom C» to A resulting in the CU67K change. (C) In index ease AB.MarW, a Cl to C change in the lirst
lusv ot uHl**n Mis llw ^iihattunon> DIUKtl ianti n*nse strand data shown). OM hi the compound heterozygote, AB.Marb.S2, the fust mutant allele has a T to 
Ci miitation ut v »ni« m i 15 te^uUmg m the V i 15CÌ substttution. tn the seciutd nuitant allele, a 4 bp deletion produces a t rameshifi in codon 334, whieheauses the premature 
termination oi the pmicm iantr^n*»e Mriiml data shown*. I El In the cointHUiiul heten»/ygote. AH.l;reiSl. the fust mutant allele has the same G to A change in codon 
WN as AIUMm2, ir ailtiui* m thr AIMM ^uhstmttuin (anti sense strami data shown), tn the second mutant allele, a C to T change in the first base of codon 33N 
intriHÌikVH a -.top f F* In AlJ.NiiSK a fomio/ygou^ (♦ to T mutation in the last base of codon W  causes the change.
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specific point mutation occurs in two unrelated families and is not 
evident in 100 test chromosomes provides further supporting 
evidence that this mutation is pathogenic and not simply a 
polymorphism. Finally, we have identified three mutant alleles 
that alter the C-terminus of the ROMK protein. Since the 
C-terminus has been shown to be important in determining pore 
properties (49), mutations in this region could affect channel 
function. In one mutant allele, a 4 bp deletion (mutation #7) 
causes a frameshift mutation at codon 334 and results in the 
introduction of a termination codon 36 amino acids downstream. 
In another mutant allele, a stop codon is substituted at R338 
(mutation #9), thereby deleting the terminal 53 residues of the 
carboxy tail. These two mutations could alter phosphorylation at 
the tyrosine kinase site at Y337, which is conserved in rat and 
human ROMK. In the third mutant allele, a glycine for Val-315 
substitution (mutation #6) lies adjacent to the cyclic AMP-de­
pendent PKA phosphorylation site in the carboxy tail which has 
been shown to be critical for channel function (47). In all affected 
individuals, these mutations would be predicted to cause loss of 
function in the channel protein.
Proposed pathogenesis of antenatal variant of Bartter 
syndrome
In the mTAL, the functional coupling of ROMK and the luminal 
Na-K-2C1 cotransporter (NKCC2) is crucial for NaCI reabsorp­
tion. Therefore, loss of function in ROMK as well as NKCC2 (28) 
would be predicted to disrupt electrogenic chloride reabsorption 
in the mTAL.
A primary defect in mTAL chloride transport is consistent with 
the complex constellation of features evident in ABS patients. 
Several lines of evidence support this proposed pathogenic 
model. Chronic inhibition of salt reabsorption in the mTAL by 
long-term furosemide treatment mimics the clinical and bio­
chemical findings in ABS, i.e. hypokalemic hypochloremic 
alkalosis, hypo- or isosthenuria, and impaired renal conservation 
of both calcium and magnesium (5,50,51). Furthermore, ABS 
patients have impaired diuretic, saluretic and hormonal responses 
to furosemide (29). In contrast, furosemide sensitivity is main­
tained in Gitelman syndrome (52), which is caused by mutations 
in the thiazide-sensitive Na-Cl cotransporter of the distal 
convoluted tubule (10).
In patients with either KCNJl or NKCC2 mutations, defective 
mTAL chloride transport results in increased NaCI delivery to the 
distal nephron with consequent salt wasting, loss of concentrating 
capacity and volume contraction. In addition, impaired electro­
genic chloride transport in mTAL also inhibits the voltage-driven, 
paracellular re absorption of calcium and magnesium (53), thus 
leading to hypercalciuria and in some patients, hypermagnesuria.
In ABS, stimulation of renal and systemic PGE2 formation is 
likely to be a secondary phenomenon, at least in those patients 
with KCNJl or NKCC2 mutations. The elevated PGE2 levels play 
a central role in disease pathogenesis (16,27). Experimental data 
demonstrate that elevated PGE2 activity stimulates the renin- 
angiotensin-aldosterone axis (54), specifically inhibits ROMK 
channel activity (48,55) and impedes NaCI transport in the mTAL 
(56,57), as well as vasopressin-induced water reabsortion in the 
collecting duct (58). Therefore, stimulation of PGE2 activity 
exacerbates the primary defect in mTAL chloride transport, 
contributes to the aldosterone-mediated hypokalemic metabolic 
alkalosis and promotes hyposthenuria. As would be predicted,
suppression of PGE2 formation with cyclo-oxygenase inhibitors, 
such as indomethacin, attenuates the salt wasting and hypoka­
lemic alkalosis and converts hyposthenuria to isosthenuria (29),
In summary, our identification of molecular defects in the 
KCNJl gene, coupled with the previously reported mutations in 
NKCC2 (28), indicate that antenatal Bartter syndrome is geneti­
cally heterogeneous. Together, these data support the hypothesis 
that ABS involves a primary mTAL transport defect (29). While 
we cannot exclude the possibility that there may be additional 
gene defects that cause ABS, these data provide new insights into 
the complex, interrelated mechanisms involved in the pathogene­
sis of antenatal Bartter syndrome. In addition, our findings 
expand the genetic basis for distinguishing Bartter-like syn­
dromes from one another. While specific disorders within the 
spectrum of Bartter-like syndromes can usually be differentiated 
by applying rigorous clinical criteria, confounding presentations 
are not unusual. Further identification of the basic genetic defects 
in Bartter-like syndromes will provide potential molecular tools 
for distinguishing specific disorders within this often confusing 
spectrum, and for dissecting the complicated pathophysiology 
involved in each disorder.
MATERIALS AND METHODS
Bartter syndrome families
Index cases from families, AB .Paris 1, AB .Marb2, AB .Marb3 and 
AB.Marb4, have been previously reported (5,19,24,29). The 
index cases of the other 10 families and the five sporadic cases 
were identified either in Neonatal Intensive Care Units or 
Pediatric Nephrology Clinics at the collaborating institutions. 
These studies were approved by local Ethics Committees and 
Informed Consent was obtained from the parents.
Genotype analysis and haplotype construction
Using standard methods, genomic DNA was extracted from whole 
blood lymphocytes of all family members studied. Markers tightly 
linked to the NKCC2 locus on chromosome 15 were typed in all of 
our families. The markers, D15S132 and D15S209 have been 
previously reported (28). The markers, D15S132-D15S143- 
D15S123 are all located on the YAC 956E3 (CEPH library) (59). 
PCR analysis using a primer set derived from the human NKCC2 
cDNA sequence amplified a 1200 bp fragment from genomic DNA 
and from YAC 956E3, confirming that this YAC contains the 
NKCC2 gene. Additional tightiy linked markers (D15982.D15S126 
and D15S121) were selected from the Genethon database (access­
ible at http://www.genethon.fr/genethon_en.html ). Highly poly­
morphic markers from the 14 cM interval on chromosome
11 q24—25 that contains the KCNJl gene were selected from the 
Genethon database (60). The following marker order for the 14 cM 
interval between D11S934 and D ll SI320 has been established by 
radiation hybrid mapping (Genome Data. Base; accessible at 
http://gdbwww.gdb.org ): cen\roma:e«DllS934-DllS912- 
DUS874-DllS910-~DllS1320-te\omero.
Microsatellite polymorphisms were amplified by the polymer­
ase chain reaction using forward primers labeled at the 5'-end 
either with fluorescent dye or y-32P. PCR reactions were 
performed in a 15 pil volume containing 50 ng of genomic DNA,
1.5 mM MgCl2,5 mM Tris (pH 8.3), 50 mMKCl, 10 pmol of each 
primer and 0.5 U of Taq polymerase. After an initial denaturation 
step at 94°C for 5 min, PCR was conducted for 30 cycles with
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dénaturation at 94°C for 45 s, annealing at 55°C for 45 s and 
extension at 72 °C for 45 s. The reaction was completed with a 
final elongation step at 72°C for 10 rain. Amplified products were 
separated on 6% polyacrylamide gels run under denaturing 
conditions. The gels were analyzed either using the Genscan 672 
software (Ver 1.2) or autoradiography. Linkage analysis was 
performed using the LINKAGE programs (61). Haplotypes were 
constructed from the genotype data. The most likely haplotypes 
were inferred by minimizing the number of crossover events in 
each sibship.
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